While epithelial ovarian cancer is characterized by a predominantly myeloid-derived immune infiltrate, our data from both the pre- and post-implantation models show a shift towards M1 macrophages with concomitant increases in T cells, namely CD8+ T cells, together indicating a strong anti-tumor shift in immune populations. Here, CD8A is linked to neoplasm.